Automatic respiratory rate monitoring may be cost effective for inpatients with pneumonia in the UK.

Continuous Monitoring of Respiratory Rate with Wearable Sensor in Patients Admitted to Hospital with Pneumonia Compared with Intermittent Nurse-Led Monitoring in the United Kingdom: A Cost-Utility Analysis. A cost-effectiveness analysis published in I Pharmcoeconomics - Open i has found that automatic respiratory rate (RR) monitoring with RespiraSense, in addition to intermittent nurse-led monitoring, for inpatients with pneumonia may be a cost-saving and cost-effective intervention in the UK "if the minimum clinical thresholds are met", say the authors. [Extracted from the article]